JPRN-UMIN000026819Completed未知
A randomized controlled trial of low-dose Enoxaparin versus low-dose Edoxavan for prevention of venous thromboembolism after total hip arthroprasty in elderly or underweight or moderate renal insufficient patients. - A RCT of anticoagulant agents for prevention of VTE after THA in elderly or underweight or moderate renal insufficient patients.
Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences0 sites76 target enrollmentStarted: April 1, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 76
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Ccr < 30 mL/min 2. common use of anticoagulant, antiplatelet and the P glucoprotein repressor 3. perioperative amount of bleeding more than 600 ml 4. allergic to iodine contrast agent 5. Under 20 years old 6. inappropriate as a study subject
Investigators
Similar Trials
Completed
Not Applicable
The effect of Enoxaparin and Aspirin for the prevention of thrombosis after open splenectomyopen splenectomy.Disease of spleen, unspecifiedIRCT2016042527600N1Vice chancellor for research, Ahvaz Jundishapur University of Medical Science126
Completed
Phase 3
A Randomized Controlled Trial of Enoxaparin Combined with Intermittent Pneumatic Compression versus Intermittent Pneumatic Compression Alone as Prophylaxis against Thromboembolism in Postoperative Gynecologic Oncology PatientsGynecologic malignancyJPRN-UMIN000005333The Jikei University School of Medicine240
Not yet recruiting
Phase 1
A randomized Controlled trial comparison of enoxaparin 40 mg versus 60 mg dosage for venous thromboembolism prophylaxis in bariatric surgeryMorbid obesity Thromboembolism Pulmonary embolism Deep vein thrombosisprophylaxisbariatric surgerymorbid obesityenoxaparinAnti-factor Xa levelvenous thromboembolismTCTR20201016001none56
Not yet recruiting
Phase 3
Evaluation of the effect of low-dose naltrexone in patients with Trigeminal Neuralgia and Chronic migraine patientsTrigeminal neuralgiaCondition 1: Trigeminal Neuralgia. Condition 2: Chronic Migraine.Chronic migraine without auraG50.0G43.7IRCT20171109037332N2Kerman University of Medical Sciences40
Recruiting
Phase 3
Enoxaparin in Treatment of Vascular Intra-Uterine Growth RetardatioIntra-uterine growth retardation.IRCT20180819040830N4Tehran University of Medical Sciences126